Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.7%
5Y CAGR+27.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+14.7%/yr
vs +162.3%/yr prior
5Y CAGR
+27.9%/yr
Recent deceleration
Acceleration
-147.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $64.32M | +20.5% |
| 2024 | $53.39M | +6.1% |
| 2023 | $50.31M | +18.0% |
| 2022 | $42.62M | +2.2% |
| 2021 | $41.71M | +121.6% |
| 2020 | $18.83M | +495.4% |
| 2019 | $3.16M | +250.9% |
| 2018 | $901000.00 | - |